Denver Public Schools is looking to recover from attendance dips that leaders say they've been seeing since COVID.

The Department of Health and Human Services cut funding for messenger ribonucleic acid vaccine development earlier this month ...

COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.

Routine screening, early detection, and prompt treatment of infections can help limit spread, and non-mRNA options like viral vector vaccines can strengthen population immunity.

He’s using Biden-era mistakes to tarnish a promising technology.

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...

The technology once embraced by President Donald Trump for speeding the development of COVID-19 vaccines is now under scrutiny. Health Secretary Robert F. Kennedy Jr. recently took sweeping action ...

A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation signature, researchers developed an mRNA-based treatment that stopped ...

DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...

Following the criticism of mRNA vaccine strategies by federal leaders, UNC Health's Dr. David Wohl shared why he supports the research.

Scientists created mRNA inhaler that makes cells produce antiviral proteins. It protected cells from flu and Zika, and ...

Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and ...